Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.0073 | 1 | 1 |
Trypanosoma cruzi | beta tubulin, putative | 0.0046 | 0 | 0.5 |
Toxoplasma gondii | beta-tubulin, putative | 0.0046 | 0 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0058 | 0.43 | 0.43 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0046 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Plasmodium falciparum | tubulin beta chain | 0.0046 | 0 | 0.5 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.0046 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0073 | 1 | 1 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0046 | 0 | 0.5 |
Giardia lamblia | Beta tubulin | 0.0046 | 0 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0073 | 1 | 1 |
Giardia lamblia | Beta tubulin | 0.0046 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Echinococcus multilocularis | tar DNA binding protein | 0.0073 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0058 | 0.43 | 0.43 |
Schistosoma mansoni | tar DNA-binding protein | 0.0073 | 1 | 1 |
Toxoplasma gondii | beta-1 tubulin, putative | 0.0046 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0073 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0073 | 1 | 1 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0046 | 0 | 0.5 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0046 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0046 | 0 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0058 | 0.43 | 0.43 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.43 | 0.43 |
Echinococcus granulosus | tar DNA binding protein | 0.0073 | 1 | 1 |
Trypanosoma brucei | beta tubulin | 0.0046 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Giardia lamblia | Beta tubulin | 0.0046 | 0 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0073 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0073 | 1 | 1 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0073 | 1 | 1 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0073 | 1 | 1 |
Plasmodium vivax | tubulin beta chain, putative | 0.0046 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0046 | 0 | 0.5 |
Toxoplasma gondii | beta tubulin | 0.0046 | 0 | 0.5 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.0046 | 0 | 0.5 |
Entamoeba histolytica | tubulin family protein | 0.0046 | 0 | 0.5 |
Trichomonas vaginalis | tubulin, putative | 0.0046 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Entamoeba histolytica | tubulin family protein | 0.0046 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0046 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Binding affinity (binding) | = 95 % | Percent displacement of [3H]-DHT binding to human androgen receptor expressed in E. coli strain HB-101 at 10 uM | ChEMBL. | 16000001 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.